Nonetheless, further studies have investigated and confirmed the correlation between high COX2 levels and the expression of tumor-promoting genes such EGR2 and IL6. Interestingly, COX2 expression has been correlated with aromatase CYP19A expression in ER-, PR-, and Her2-positive breast cancers [116]. This evidence concerns the gene ERBB2 and neoplasm.